Wird geladen...
The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII
BACKGROUND: Recombinant activated factor VII (rFVIIa) has been widely used as an off-licence pan-haemostatic agent in patients with critical bleeding. However, outside the trauma setting, there is relatively little high quality evidence on the risks and benefits of this agent. The Haemostasis Regist...
Gespeichert in:
| Veröffentlicht in: | Blood Transfus |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Edizioni SIMTI - SIMTI Servizi Srl
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4317095/ https://ncbi.nlm.nih.gov/pubmed/24960661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2014.0260-13 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|